Works matching IS 10837159 AND DT 2022 AND VI 27 AND IP 6

Results: 24

Supreme Court and the Practice of Oncology.

Published in:

2022

By:

Chabner, Bruce A;
Bates, Susan E

Publication type:

Editorial

Systemic Therapies Following Progression on First-line CDK4/6-inhibitor Treatment: Analysis of Real-world Data.

Published in:

Oncologist, 2022, v. 27, n. 6, p. 441, doi. 10.1093/oncolo/oyac075

By:

Martin, James M;
Handorf, Elizabeth A;
Montero, Alberto J;
Goldstein, Lori J

Publication type:

Article

Update to "Homologous Recombination Repair Defect May Predict Treatment Response to Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors".

Published in:

Oncologist, 2022, v. 27, n. 6, p. e534, doi. 10.1093/oncolo/oyac068

By:

Zhu, Mojun;
Bekaii-Saab, Tanios

Publication type:

Article

Sonidegib with and Without Adjunctive Treatment for Locally Advanced Basal Cell Carcinomas.

Published in:

Oncologist, 2022, v. 27, n. 6, p. e533, doi. 10.1093/oncolo/oyac063

By:

Villani, Alessia;
Fabbrocini, Gabriella;
Costa, Claudia;
Potestio, Luca;
Scalvenzi, Massimiliano

Publication type:

Article

Blood-Based Next-Generation Sequencing in Adrenocortical Carcinoma.

Published in:

Oncologist, 2022, v. 27, n. 6, p. 462, doi. 10.1093/oncolo/oyac061

By:

Nazha, Bassel;
Zhuang, Tony Z;
Dada, Hiba I;
Drusbosky, Leylah M;
Brown, Jacqueline T;
Ravindranathan, Deepak;
Carthon, Bradley C;
Kucuk, Omer;
Goldman, Jamie;
Master, Viraj A;
Bilen, Mehmet Asim

Publication type:

Article

One-Day Versus Three-Day Dexamethasone with NK1RA for Patients Receiving Carboplatin and Moderate Emetogenic Chemotherapy: A Network Meta-analysis.

Published in:

Oncologist, 2022, v. 27, n. 6, p. e524, doi. 10.1093/oncolo/oyac060

By:

Watanabe, Daichi;
Iihara, Hirotoshi;
Fujii, Hironori;
Makiyama, Akitaka;
Nishida, Shohei;
Suzuki, Akio

Publication type:

Article

Signal Detection of Adverse Events Associated with Trastuzumab in a Cohort of Elderly Patients with Breast Cancer.

Published in:

Oncologist, 2022, v. 27, n. 6, p. 434, doi. 10.1093/oncolo/oyac059

By:

Polychronopoulou, Efstathia;
Giordano, Sharon H;
Chou, Lin-Na;
Yu, Xiaoying;
Kuo, Yong-Fang

Publication type:

Article

Efficacy and Safety of Apatinib in Patients with Recurrent or Refractory Melanoma.

Published in:

Oncologist, 2022, v. 27, n. 6, p. e463, doi. 10.1093/oncolo/oyab068

By:

Yuan, Shumin;
Fu, Qiang;
Zhao, Lingdi;
Fu, Xiaomin;
Li, Tiepeng;
Han, Lu;
Qin, Peng;
Ren, Yingkun;
Huo, Mingke;
Li, Zhimeng;
Lu, Chaomin;
Yuan, Long;
Gao, Quanli;
Wang, Zibing

Publication type:

Article

Impact of the COVID-19 Pandemic on Management of Patients with Metastatic Pancreatic Ductal Adenocarcinoma in the United States.

Published in:

Oncologist, 2022, v. 27, n. 6, p. e518, doi. 10.1093/oncolo/oyac029

By:

Paluri, Ravi;
Laursen, Ashley;
Gaeta, Joseph;
Wang, Shu;
Surinach, Andy;
Cockrum, Paul

Publication type:

Article

Evaluation of Liver and Renal Toxicity in Peptide Receptor Radionuclide Therapy for Somatostatin Receptor Expressing Tumors: A 2-Year Follow-Up.

Published in:

Oncologist, 2022, v. 27, n. 6, p. 447, doi. 10.1093/oncolo/oyab072

By:

Duan, Heying;
Ferri, Valentina;
Fisher, George Albert;
Shaheen, Shagufta;
Davidzon, Guido Alejandro;
Iagaru, Andrei;
Aparici, Carina Mari

Publication type:

Article

Marital Status, Living Arrangement, and Cancer Recurrence and Survival in Patients with Stage III Colon Cancer: Findings from CALGB 89803 (Alliance).

Published in:

Oncologist, 2022, v. 27, n. 6, p. e494, doi. 10.1093/oncolo/oyab070

By:

Lee, Seohyuk;
Ma, Chao;
Zhang, Sui;
Ou, Fang-Shu;
Bainter, Tiffany M;
Niedzwiecki, Donna;
Saltz, Leonard B;
Mayer, Robert J;
Whittom, Renaud;
Hantel, Alexander;
Benson, Al;
Atienza, Daniel;
Kindler, Hedy;
Gross, Cary P;
Irwin, Melinda L;
Meyerhardt, Jeffrey A;
Fuchs, Charles S

Publication type:

Article

Clinical Progress in Inoperable or Recurrent Advanced Gastric Cancer Treatment from 1004 Single Institute Experiences Between 2007 and 2018.

Published in:

Oncologist, 2022, v. 27, n. 6, p. e506, doi. 10.1093/oncolo/oyab069

By:

Nakayama, Izuma;
Takahari, Daisuke;
Shimozaki, Keitaro;
Chin, Keisho;
Wakatsuki, Takeru;
Ogura, Mariko;
Ooki, Akira;
Kamiimabeppu, Daisaku;
Osumi, Hiroki;
Shinozaki, Eiji;
Yamaguchi, Kensei

Publication type:

Article

Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving Nivolumab.

Published in:

Oncologist, 2022, v. 27, n. 6, p. e484, doi. 10.1093/oncolo/oyac051

By:

Pasello, Giulia;
Lorenzi, Martina;
Calvetti, Lorenzo;
Oliani, Cristina;
Pavan, Alberto;
Favaretto, Adolfo;
Palazzolo, Giovanni;
Giovanis, Petros;
Zustovich, Fable;
Bonetti, Andrea;
Bernardi, Daniele;
Mandarà, Marta;
Aprile, Giuseppe;
Crivellaro, Giovanna;
Sinigaglia, Giusy;
Tognazzo, Sandro;
Morandi, Paolo;
Bortolami, Alberto;
Marino, Valentina;
Bonanno, Laura

Publication type:

Article

ADXS31142 Immunotherapy ± Pembrolizumab Treatment for Metastatic Castration-Resistant Prostate Cancer: Open-Label Phase I/II KEYNOTE-046 Study.

Published in:

Oncologist, 2022, v. 27, n. 6, p. 453, doi. 10.1093/oncolo/oyac048

By:

Stein, Mark N;
Fong, Lawrence;
Tutrone, Ronald;
Mega, Anthony;
Lam, Elaine T;
Parsi, Megan;
Vangala, Surya;
Gutierrez, Andres A;
Haas, Naomi B

Publication type:

Article

Doctor Will FaceTime You Now: Commentary on Telehealth in Cancer Care.

Published in:

Oncologist, 2022, v. 27, n. 6, p. 428, doi. 10.1093/oncolo/oyac044

By:

Feinberg, Jacqueline;
Sonoda, Yukio

Publication type:

Article

FDA Approval Summary: Ruxolitinib for Treatment of Chronic Graft-Versus-Host Disease after Failure of One or Two Lines of Systemic Therapy.

Published in:

Oncologist, 2022, v. 27, n. 6, p. 493, doi. 10.1093/oncolo/oyac042

By:

Le, Robert Q;
Wang, Xin;
Zhang, Hongfei;
Li, Hongshan;
Przepiorka, Donna;
Vallejo, Jonathon;
Leong, Ruby;
Ma, Lian;
Goldberg, Kirsten B;
Pazdur, Richard;
Theoret, Marc R;
Claro, Angelo De

Publication type:

Article

Perception of Telehealth During the COVID-19 Pandemic Among Survivors of Gynecologic Cancer.

Published in:

Oncologist, 2022, v. 27, n. 6, p. 512, doi. 10.1093/oncolo/oyac041

By:

Quam, Nicholas;
Stenzel, Ashley E;
Brown, Katherine;
Jewett, Patricia;
Parsons, Helen M;
Hui, Jane;
Ghebre, Rahel G;
Blaes, Anne;
Teoh, Deanna;
Vogel, Rachel I

Publication type:

Article

Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint Inhibitors.

Published in:

Oncologist, 2022, v. 27, n. 6, p. 501, doi. 10.1093/oncolo/oyac040

By:

Gantzer, Justine;
Davidson, Guillaume;
Vokshi, Bujamin;
Weingertner, Noëlle;
Bougoüin, Antoine;
Moreira, Marco;
Lindner, Véronique;
Lacroix, Guillaume;
Mascaux, Céline;
Chenard, Marie-Pierre;
Bertucci, François;
Davidson, Irwin;
Kurtz, Jean-Emmanuel;
Sautès-Fridman, Catherine;
Fridman, Wolf H;
Malouf, Gabriel G

Publication type:

Article

Artificial Intelligence-based Radiomics in the Era of Immuno-oncology.

Published in:

Oncologist, 2022, v. 27, n. 6, p. e471, doi. 10.1093/oncolo/oyac036

By:

Kang, Cyra Y;
Duarte, Samantha E;
Kim, Hye Sung;
Kim, Eugene;
Park, Jonghanne;
Lee, Alice Daeun;
Kim, Yeseul;
Kim, Leeseul;
Cho, Sukjoo;
Oh, Yoojin;
Gim, Gahyun;
Park, Inae;
Lee, Dongyup;
Abazeed, Mohamed;
Velichko, Yury S;
Chae, Young Kwang

Publication type:

Article

Targeted Next-Generation Sequencing Reveals Exceptionally High Rates of Molecular Driver Mutations in Never-Smokers With Lung Adenocarcinoma.

Published in:

Oncologist, 2022, v. 27, n. 6, p. 476, doi. 10.1093/oncolo/oyac035

By:

Mack, Philip C;
Klein, Michael I;
Ayers, Kristin L;
Zhou, Xiang;
Guin, Sunny;
Fink, Marc;
Rossi, Michael;
AI-Kateb, Hussam;
O'Connell, Timmy;
Hantash, Feras M;
Oh, William K;
Newman, Scott;
Schadt, Eric E;
Chen, Rong;
Hirsch, Fred R

Publication type:

Article

Real-world Impact of Age at Diagnosis on Treatment Patterns and Survival Outcomes of Patients with Metastatic Pancreatic Ductal Adenocarcinoma.

Published in:

Oncologist, 2022, v. 27, n. 6, p. 469, doi. 10.1093/oncolo/oyac028

By:

Elias, Rawad;
Cockrum, Paul;
Surinach, Andy;
Wang, Shu;
Chu, Bong Chul;
Shahrokni, Armin

Publication type:

Article

Phase Ib Study of Lucitanib (AL3810) in a Cohort of Patients with Recurrent and Metastatic Nasopharyngeal Carcinoma.

Published in:

Oncologist, 2022, v. 27, n. 6, p. e453, doi. 10.1093/oncolo/oyab076

By:

Zhang, Yang;
Luo, Fan;
Ma, Yu-Xiang;
Liu, Qian-Wen;
Yang, Yun-Peng;
Fang, Wen-Feng;
Huang, Yan;
Zhou, Ting;
Li, Jin;
Pan, Hong-Ming;
Yang, Lei;
Qin, Shu-Kui;
Zhao, Hong-Yun;
Zhang, Li

Publication type:

Article

Phase II Clinical and Translational Study of Everolimus ± Paclitaxel as First-Line Therapy in Cisplatin-Ineligible Advanced Urothelial Carcinoma.

Published in:

Oncologist, 2022, v. 27, n. 6, p. 432, doi. 10.1093/oncolo/oyab075

By:

Jun, Tomi;
Hahn, Noah M;
Sonpavde, Guru;
Albany, Constantine;
MacVicar, Gary R;
Hauke, Ralph;
Fleming, Mark;
Gourdin, Theodore;
Jana, Bagi;
Oh, William K;
Taik, Patricia;
Wang, Huan;
Varadarajan, Ajay Ramakrishnan;
Uzilov, Andrew;
Galsky, Matthew D

Publication type:

Article

Photochemical Internalization of Gemcitabine Is Safe and Effective in Locally Advanced Inoperable Cholangiocarcinoma.

Published in:

Oncologist, 2022, v. 27, n. 6, p. 430, doi. 10.1093/oncolo/oyab074

By:

Trojan, Jörg;
Hoffmeister, Albrecht;
Neu, Bruno;
Kasper, Stefan;
Dechêne, Alexander;
Jürgensen, Christian;
Schirra, Jörg;
Jakobs, Ralf;
Palmer, Dan;
Selbo, Pål k.;
Olivecrona, Hans;
Finnesand, Lena;
Høgset, Anders;
Walday, Per;
Sturgess, Richard

Publication type:

Article